ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ADMA Adma Biologics Inc

6.58
0.00 (0.00%)
プレマーケット
最終更新日: 20:35:21
15分遅延
名称 銘柄コード 市場 種別
Adma Biologics Inc ADMA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 6.58 20:35:21
始値 安値 高値 終値 前日終値
6.58
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1205:05EDGAR2Form 8-K - Current report
2024/3/1201:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/3/1120:00GLOBEADMA Biologics Announces FDA Approvals of Extended Room..
2024/3/0911:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:05EDGAR2Form 8-K - Current report
2024/3/0521:00GLOBEADMA Biologics to Participate in the Raymond James..
2024/3/0511:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2911:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2906:21EDGAR2Form 8-K - Current report
2024/2/2906:15EDGAR2Form 8-K - Current report
2024/2/2906:10GLOBEADMA Biologics Announces CFO Transition
2024/2/2906:05GLOBEADMA Biologics Announces Fourth Quarter and Full Year 2023..
2024/2/2811:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:05GLOBEADMA Biologics to Report Fourth Quarter and Full Year 2023..
2024/2/2122:00EDGAR2Form 8-K - Current report
2024/2/2121:00GLOBEADMA Biologics Successfully Implements Innovative AI..
2024/2/1501:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0822:00EDGAR2Form 8-K - Current report
2024/1/0821:30EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBEADMA Biologics Announces Preliminary Fourth Quarter 2023..
2024/1/0611:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1906:05GLOBEADMA Biologics Announces $135 Million Non-Dilutive..
2023/12/1306:30EDGAR2Form 8-K - Current report
2023/12/1221:00GLOBEADMA Biologics Announces FDA Approval for BIVIGAM® in the..
2023/11/1706:31EDGAR2Form 8-K - Current report
2023/11/1621:00GLOBEADMA BioCenters Receives FDA Approval for its Tenth Plasma..
2023/11/0907:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:36EDGAR2Form 8-K - Current report
2023/11/0906:05GLOBEADMA Biologics Announces Third Quarter 2023 Financial..
2023/11/0120:00GLOBEADMA Biologics to Report Third Quarter 2023 Financial..
2023/10/0410:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0305:45EDGAR2Form 8-K - Current report
2023/8/3105:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2508:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2306:09EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1910:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1901:58EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
2023/8/1810:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1509:47EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1006:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:15EDGAR2Form 8-K - Current report
2023/8/1005:05GLOBEADMA Biologics Announces Second Quarter 2023 Financial..
2023/8/0220:00GLOBEADMA Biologics to Report Second Quarter 2023 Financial..
2023/7/1920:30EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock